Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Asahi Kasei acquires German company Aicuris

 April 21, 2026

Pharmaceutical Business Review

The move comes after Asahi Kasei signed a definitive agreement to acquire all issued shares of Aicuris for approximately 780m ($920.7m) earlier this year.

M&A / DealsRead full story

Post navigation

Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy →
← Eli Lilly doubles down on in vivo with $7bn Kelonia buyout

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com